Vascular abnormalities in surgical specimens obtained from the resected focus of intractable epilepsy

Brain Tumor Pathology
A HodozukaT Tanaka

Abstract

The histopathological features, particularly hypervascularity, were examined in specimens resected from 21 patients, 15 with intractable epilepsy accompanying cortical dysplasia or dysembryoplastic neuroepithelial tumor (DNT), and 6 with benign brain tumors, such as ganglioglioma and low-grade glioma. Hypervascularity was found in resected specimens from 15 of the 21 patients (71.4%) and in 10 of the 12 patients (83.3%) who had double pathology. Counting of numbers of vessels by CD31 immunohistochemistry revealed that hypervascularity was prominent, especially in cases of vascular malformation or cortical dysplasia. However, almost all cases were negative for vascular endothelial growth factor (VEGF) staining, except for some cases of benign brain tumors. Moreover, all cases showed low or no proliferative potential in MIB-1 immunohistochemistry. These results suggest that the etiology of hypervascularity in the dysplastic lesions is one of a variety of cerebral malformations, as is the case with abnormal maturation and differentiation in neuroglial elements.

References

Jan 1, 1990·Journal of Neuropathology and Experimental Neurology·J J KepesJ Flasschoen
Jul 8, 1988·Science·P Rakic
Aug 1, 1971·Journal of Neurology, Neurosurgery, and Psychiatry·D C TaylorJ A Corsellis
Sep 1, 1993·Journal of Neuropathology and Experimental Neurology·D D Armstrong
Sep 1, 1993·Journal of Neuropathology and Experimental Neurology·H K WolfO D Wiestler

❮ Previous
Next ❯

Citations

Nov 28, 2012·Seizure : the Journal of the British Epilepsy Association·Ann Kristin SchmitzPitt Niehusmann
Jan 8, 2008·Developmental Medicine and Child Neurology·Karl TitzeHans-Christoph Steinhausen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.